Synopsis of recent research by authors named "ChengHan Wu"
- ChengHan Wu's recent research explores the interplay between inflammation, glycation products, and cancer, focusing on how pre-treatment pan-immune-inflammation value can serve as a prognostic marker in soft tissue sarcoma treatment with pazopanib, highlighting the importance of inflammation in targeted therapies.
- Additionally, Wu investigates advanced glycation end-products (AGEs) as immunomodulators, emphasizing their role in chronic inflammation and age-related diseases, particularly in patients with metabolic and immune-related conditions.
- Wu's work also extends into materials science, showcasing innovative developments in supercapacitor efficiency through the use of nitrogen-doped graphene aerogels, which exhibit remarkable performance characteristics across various pH levels, indicating potential for energy storage applications.
